Medistim ASA (STO:MEDIO)

Market Cap	4.11B
Revenue (ttm)	590.40M
Net Income (ttm)	123.27M
Shares Out	n/a
EPS (ttm)	6.74
PE Ratio	33.32
Forward PE	29.61
Dividend	n/a
Ex-Dividend Date	n/a

Volume	84
Average Volume	129
Open	240.00
Previous Close	241.00
Day's Range	240.00 - 240.00
52-Week Range	131.00 - 276.00
Beta	n/a
RSI	52.58
Earnings Date	Oct 24, 2025

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1984
• Employees: 154
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MEDIO

Financial Performance

In 2024, Medistim ASA's revenue was 556.16 million, an increase of 6.73% compared to the previous year's 521.11 million. Earnings were 103.83 million, an increase of 0.01%.

Financial numbers in NOK